Clinical Trial Update: Study of Weekly Clofarabine for the Treatment of Relapsed/Refractory Chronic Lymphocytic Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating weekly clofarabine for relapsed/refractory chronic lymphocytic leukemia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Leukemia

Drugs mentioned

• Clolar (Clofarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Lymphocytic Leukemia, Leukemia | Phase 1 | Status: TERMINATED